Drilldown: Medicines

Codeine (2)

Other values:

Search

None (80) · (multiple, generic dominant) (1) · Adderall, Adderall XR, Mydayis (1) · Captagon (1) · Darvon (1) · Delysid (historical, Sandoz, withdrawn 1965) (1) · Demerol (1) · Desoxyn (1) · Dexedrine (1) · Dilaudid (1) · Duragesic (1) · Nubain (1) · Nucynta (1) · Opana (1) · Stadol (1) · Talwin (1) · Vicodin (1)

Research material · Classic Psychedelic · Stimulant · Opioid · Sedative-Hypnotic · Phenethylamine · Tryptamine · Benzodiazepine · Botanical · [[:Category:Antihypertensives|Antihypertensive]] · Dissociative · Anticonvulsant · Antidepressant · Plant Medicine · Analgesic · Antiparkinsonian · Antipsychotic · Empathogen · Neuroleptic · Cathinone

Other values:

Search

5-HT2A agonist (26) · Monoamine releasing agent (6) · Potent 5-HT2A agonist (5) · LSD analogue; 5-HT2A agonist (4) · Mu-opioid receptor agonist (4) · Prodrug of LSD; 5-HT2A agonist (4) · Potent mu-opioid receptor agonist (3) · Contains LSA (2) · Contains mescaline (2)

Other values:

Search

None (93) · Mild to moderate pain; cough suppression (low-dose). (1) · '"`UNIQ--vote-000004B9-QINU`"', '"`UNIQ--vote-000004BA-QINU`"', '"`UNIQ--vote-000004BB-QINU`"' (1) · '"`UNIQ--vote-00000562-QINU`"', '"`UNIQ--vote-00000563-QINU`"', '"`UNIQ--vote-00000564-QINU`"', '"`UNIQ--vote-00000565-QINU`"', '"`UNIQ--vote-00000566-QINU`"' (1)

None (93) · 2.5 mg IR, 5 mg XR, or 12.5mg Mydayis (1) · 5 mg PO (1) · Adult: 15–60 mg every 4 hours as needed. (1)

None (93) · Desoxyn 5 mg tabs (1) · IR tabs 5, 7.5, 10, 12.5, 15, 20, 30 mg; XR caps 5, 10, 15, 20, 25, 30 mg; Mydayis caps 12.5, 25, 37.5, 50 mg (1) · Tablet (15, 30, 60 mg); oral solution; combination products (with [[Acetaminophen|acetaminophen]] or ibuprofen). (1)

None (93) · 25 mg/day (ADHD per Desoxyn label); 15 mg/day (obesity, short-term, per Desoxyn label) (1) · 360 mg/day (1) · XR = 40 or 60 mg/d; IR = 40 or 60 mg/d'"`UNIQ--ref-00000567-QINU`"' (1)

None (92) · Oral (2) · Oral (prescribed) (1) · PO (only formulation marketed in the US). (1)

None (93) · 30–60 min (PO) (1) · 30–60 minutes (1) · IR: 30–60 min; XR: 1–2 h to peak effect (1)

None (93) · 4–6 hours (1) · 8–12 hours (1) · IR 4–6 h; XR 10–12 h; Mydayis 14–16 h (1)

None (93) · 2.5–3 hours (1) · 3–5 hours (1) · D-amphetamine ~10 h; L-amphetamine ~13 h (adults) (1)

None (93) · 70–90% (oral) (1) · ~50% (variable, CYP2D6-dependent for analgesic effect). (1) · ~75–90% (oral) (1)

None (92) · Avoid; risk of neonatal opioid withdrawal with chronic use; UM-mother breastfeeding contraindicated. (1) · Category C (1) · Category C (per Desoxyn label) (1) · Not established (1)

None (92) · Schedule I (United States) (1) · Schedule II (2) · US Schedule II (single-entity); Schedule III–V (combination products by content). (1)